{"cluster": 57, "subcluster": 12, "abstract_phrases": [{"text": "\u2022 myasthenia gravis \u2022 treatment", "rank": 0.076}, {"text": "patients", "rank": 0.073}, {"text": "first patient", "rank": 0.071}, {"text": "older patients", "rank": 0.068}, {"text": "adult patients", "rank": 0.068}], "title_phrases": [{"text": "patients", "rank": 0.123}, {"text": "randomised controlled trial", "rank": 0.123}, {"text": "randomised controlled trialproactive", "rank": 0.12}, {"text": "randomised controlled trialazithromycin", "rank": 0.12}, {"text": "randomised controlled trialtreatment", "rank": 0.118}], "title_abstract_phrases": [{"text": "patients", "rank": 0.076}, {"text": "\u2022 myasthenia gravis \u2022 treatment", "rank": 0.075}, {"text": "first patient", "rank": 0.073}, {"text": "older patients", "rank": 0.071}, {"text": "adult patients", "rank": 0.071}]}